Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study (Q33953931)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study |
scientific article |
Statements
1 reference
Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study (English)
1 reference
Rieke Alten
1 reference
Juan Gomez-Reino
1 reference
Patrick Durez
1 reference
Andre Beaulieu
1 reference
Anthony Sebba
1 reference
Gerhard Krammer
1 reference
Ralph Preiss
1 reference
Udayasankar Arulmani
1 reference
Albert Widmer
1 reference
Xavier Gitton
1 reference
Herbert Kellner
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference